{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:07:40Z","timestamp":1793210860612,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T00:00:00Z","timestamp":1603152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T00:00:00Z","timestamp":1603152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Polyautoimmunity implicates that some autoimmune diseases share common etiopathogenesis. Some studies have reported an association between multiple sclerosis (MS) and vitiligo; meanwhile, other studies have failed to confirm this association. We performed a systemic review and meta-analysis to examine the association of MS with vitiligo. We searched the MEDLINE and Embase databases on March 8, 2020 for relevant case\u2013control, cross-sectional, and cohort studies. The Newcastle\u2013Ottawa Scale was used to evaluate the risk of bias of the included studies. Where applicable, we performed a meta-analysis to calculate the pooled odds ratio (OR) for case\u2013control\/cross-sectional studies and risk ratio for cohort studies with 95% confidence interval (CI). Our search identified 285 citations after removing duplicates. Six case\u2013control studies with 12,930 study subjects met our inclusion criteria. Our meta-analysis found no significant association of MS with prevalent vitiligo (pooled OR 1.33; 95% CI 0.80\u20122.22). Analysis of the pooled data failed to display any increase of prevalent vitiligo in MS patients compared with controls. Ethnic and genetic factors may play an important role for sporadically observed associations between MS and vitiligo. Future studies of this association should therefore consider stratification by ethnic or genetic factors.<\/jats:p>","DOI":"10.1038\/s41598-020-74298-0","type":"journal-article","created":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T10:03:16Z","timestamp":1603188196000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Association of multiple sclerosis with vitiligo: a systematic review and meta-analysis"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4714-424X","authenticated-orcid":false,"given":"Meng-Han","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7576-963X","authenticated-orcid":false,"given":"Chau Yee","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4972-9823","authenticated-orcid":false,"given":"Kuo-Hsuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5699-0283","authenticated-orcid":false,"given":"Ching-Chi","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,20]]},"reference":[{"key":"74298_CR1","first-page":"S15","volume":"19","author":"MJ Tullman","year":"2013","unstructured":"Tullman, M. J. Overview of the epidemiology, diagnosis, and disease progression associated with multiple sclerosis. Am. J. Manage. Care 19, S15-20 (2013).","journal-title":"Am. J. Manage. Care"},{"key":"74298_CR2","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson, A. J. et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 17, 162\u2013173 (2018).","journal-title":"Lancet Neurol."},{"key":"74298_CR3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s100720170011","volume":"22","author":"G Rosati","year":"2001","unstructured":"Rosati, G. The prevalence of multiple sclerosis in the world: an update. Neurol. Sci. 22, 117\u2013139. https:\/\/doi.org\/10.1007\/s100720170011 (2001).","journal-title":"Neurol. Sci."},{"key":"74298_CR4","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1089\/ars.2012.5068","volume":"19","author":"D Miljkovi\u0107","year":"2013","unstructured":"Miljkovi\u0107, D. & Spasojevi\u0107, I. Multiple sclerosis: molecular mechanisms and therapeutic opportunities. Antioxid. Redox Signal. 19, 2286\u20132334 (2013).","journal-title":"Antioxid. Redox Signal."},{"key":"74298_CR5","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1111\/j.1365-4632.2011.05377.x","volume":"51","author":"C Kr\u00fcger","year":"2012","unstructured":"Kr\u00fcger, C. & Schallreuter, K. U. A review of the worldwide prevalence of vitiligo in children\/adolescents and adults. Int. J. Dermatol. 51, 1206\u20131212. https:\/\/doi.org\/10.1111\/j.1365-4632.2011.05377.x (2012).","journal-title":"Int. J. Dermatol."},{"key":"74298_CR6","doi-asserted-by":"publisher","first-page":"221","DOI":"10.12998\/wjcc.v3.i3.221","volume":"3","author":"GF Mohammed","year":"2015","unstructured":"Mohammed, G. F., Gomaa, A. H. & Al-Dhubaibi, M. S. Highlights in pathogenesis of vitiligo. World J. Clin. Cases. 3, 221 (2015).","journal-title":"World J. Clin. Cases."},{"key":"74298_CR7","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1185\/030079906X104641","volume":"22","author":"D Robinson Jr","year":"2006","unstructured":"Robinson, D. Jr. et al. Co-occurrence and comorbidities in patients with immune-mediated inflammatory disorders: an exploration using US healthcare claims data, 2001\u20132002. Curr. Med. Res. Opin. 22, 989\u20131000 (2006).","journal-title":"Curr. Med. Res. Opin."},{"key":"74298_CR8","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s40257-018-0399-9","volume":"20","author":"CY Liu","year":"2019","unstructured":"Liu, C. Y, et al. Association of multiple sclerosis with psoriasis: a systematic review and meta-analysis of observational studies. Am. J. Clin. Dermatol. 20, 201\u2013208 (2019).","journal-title":"Am. J. Clin. Dermatol."},{"key":"74298_CR9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1177\/1352458514564491","volume":"21","author":"RA Marrie","year":"2015","unstructured":"Marrie, R. A. et al. A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview. Mult. Scler. J. 21, 263\u2013281 (2015).","journal-title":"Mult. Scler. J."},{"key":"74298_CR10","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.jaad.2010.11.061","volume":"65","author":"A Alikhan","year":"2011","unstructured":"Alikhan, A., Felsten, L. M., Daly, M. & Petronic-Rosic, V. Vitiligo: a comprehensive overview: part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. J. Am. Acad. Dermatol. 65, 473\u2013491 (2011).","journal-title":"J. Am. Acad. Dermatol."},{"key":"74298_CR11","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher, D., Liberati, A., Tetzlaff, J. & Altman, D. G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 6, e1000097. https:\/\/doi.org\/10.1371\/journal.pmed.1000097 (2009).","journal-title":"PLoS Med."},{"key":"74298_CR12","unstructured":"Peterson, J., Welch, V., Losos, M. & Tugwell, P. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. (2011 Available from: https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp.)."},{"key":"74298_CR13","unstructured":"Review Manager (RevMan)[Computer Program] Version 5.3. Copenhagen: The Cochrane Colaboration. 2014."},{"key":"74298_CR14","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins, J. P. & Thompson, S. G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 21, 1539\u20131558 (2002).","journal-title":"Stat. Med."},{"key":"74298_CR15","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1037\/1082-989X.11.2.193","volume":"11","author":"TB Huedo-Medina","year":"2006","unstructured":"Huedo-Medina, T. B., S\u00e1nchez-Meca, J., Mar\u00edn-Mart\u00ednez, F. & Botella, J. Assessing heterogeneity in meta-analysis: Q statistic or I2 index?. Psychol. Methods 11, 193 (2006).","journal-title":"Psychol. Methods"},{"key":"74298_CR16","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger, M., Smith, G. D., Schneider, M. & Minder, C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629\u2013634 (1997).","journal-title":"BMJ"},{"key":"74298_CR17","doi-asserted-by":"publisher","first-page":"d4002","DOI":"10.1136\/bmj.d4002","volume":"343","author":"JA Sterne","year":"2011","unstructured":"Sterne, J. A. et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 343, d4002 (2011).","journal-title":"BMJ"},{"key":"74298_CR18","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/ane.12308","volume":"131","author":"G Deretzi","year":"2015","unstructured":"Deretzi, G. et al. Polyautoimmunity in a Greek cohort of multiple sclerosis. Acta. Neurol. Scand. 131, 225\u2013230 (2015).","journal-title":"Acta. Neurol. Scand."},{"key":"74298_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1600-0404.1990.tb00928.x","volume":"81","author":"S Seyfert","year":"1990","unstructured":"Seyfert, S., Klapps, P., Meisel, C., Fischer, T. & Junghan, U. Multiple sclerosis and other immunologic diseases. Acta. Neurol. Scand. 81, 37\u201342 (1990).","journal-title":"Acta. Neurol. Scand."},{"key":"74298_CR20","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1054\/jocn.2000.0693","volume":"7","author":"RD Henderson","year":"2000","unstructured":"Henderson, R. D., Bain, C. J. & Pender, M. P. The occurrence of autoimmune diseases in patients with multiple sclerosis and their families. J. Clin. Neurosci. 7, 434\u2013437 (2000).","journal-title":"J. Clin. Neurosci."},{"key":"74298_CR21","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1007\/s00415-006-0084-4","volume":"253","author":"A Laroni","year":"2006","unstructured":"Laroni, A. et al. Multiple sclerosis and autoimmune diseases: epidemiology and HLA-DR association in North-east Italy. J. Neurol. 253, 636\u2013639 (2006).","journal-title":"J. Neurol."},{"key":"74298_CR22","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/S1474-4422(07)70132-1","volume":"6","author":"SV Ramagopalan","year":"2007","unstructured":"Ramagopalan, S. V. et al. Autoimmune disease in families with multiple sclerosis: a population-based study. Lancet Neurol. 6, 604\u2013610 (2007).","journal-title":"Lancet Neurol."},{"key":"74298_CR23","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1177\/1352458510369146","volume":"16","author":"A Langer-Gould","year":"2010","unstructured":"Langer-Gould, A., Albers, K., Van Den Eeden, S. & Nelson, L. Autoimmune diseases prior to the diagnosis of multiple sclerosis: a population-based case-control study. Mult. Scler. J. 16, 855\u2013861 (2010).","journal-title":"Mult. Scler. J."},{"key":"74298_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0303-8467(00)00125-6","volume":"103","author":"CM Poser","year":"2001","unstructured":"Poser, C. M. & Brinar, V. V. Diagnostic criteria for multiple sclerosis. Clin. Neurol. Neurosurg. 103, 1\u201311 (2001).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"74298_CR25","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/ana.20703","volume":"58","author":"CH Polman","year":"2005","unstructured":"Polman, C. H. et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald Criteria\u201d. Ann. Neurol. 58, 840\u2013846 (2005).","journal-title":"Ann. Neurol."},{"key":"74298_CR26","doi-asserted-by":"publisher","first-page":"e4346","DOI":"10.1371\/journal.pone.0004346","volume":"4","author":"Y Li","year":"2009","unstructured":"Li, Y. & Agarwal, P. A pathway-based view of human diseases and disease relationships. PLoS ONE 4, e4346 (2009).","journal-title":"PLoS ONE"},{"key":"74298_CR27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41572-018-0050-3","volume":"4","author":"M Filippi","year":"2018","unstructured":"Filippi, M. et al. Multiple sclerosis (primer). Nat. Rev. Dis. Primers 4, 49\u201349 (2018).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"74298_CR28","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1056\/NEJMoa073493","volume":"357","author":"Consortium, I. M. S. G","year":"2007","unstructured":"Consortium, I. M. S. G. Risk alleles for multiple sclerosis identified by a genomewide study. N. Engl. J. Med. 357, 851\u2013862 (2007).","journal-title":"N. Engl. J. Med."},{"key":"74298_CR29","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/jid.2011.463","volume":"132","author":"JE Harris","year":"2012","unstructured":"Harris, J. E. et al. A mouse model of vitiligo with focused epidermal depigmentation requires IFN-\u03b3 for autoreactive CD8+ T-cell accumulation in the skin. J. Invest. Dermatol. 132, 1869\u20131876 (2012).","journal-title":"J. Invest. Dermatol."},{"key":"74298_CR30","doi-asserted-by":"crossref","unstructured":"Rashighi, M. et al. CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo. Sci. Transl. Med. 6, 223ra223\u2013223ra223 (2014).","DOI":"10.1126\/scitranslmed.3007811"},{"key":"74298_CR31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jdermsci.2015.09.003","volume":"81","author":"H Xie","year":"2016","unstructured":"Xie, H. et al. Vitiligo: How do oxidative stress-induced autoantigens trigger autoimmunity?. J. Dermatol. Sci. 81, 3\u20139 (2016).","journal-title":"J. Dermatol. Sci."},{"key":"74298_CR32","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/jid.2011.321","volume":"132","author":"RA Spritz","year":"2012","unstructured":"Spritz, R. A. Six decades of vitiligo genetics: genome-wide studies provide insights into autoimmune pathogenesis. J. Invest. Dermatol. 132, 268\u2013273 (2012).","journal-title":"J. Invest. Dermatol."},{"key":"74298_CR33","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.msard.2017.07.020","volume":"17","author":"ML Degelman","year":"2017","unstructured":"Degelman, M. L. & Herman, K. M. Smoking and multiple sclerosis: a systematic review and meta-analysis using the Bradford Hill criteria for causation. Mult. Scler. Relat. Disord. 17, 207\u2013216 (2017).","journal-title":"Mult. Scler. Relat. Disord."},{"key":"74298_CR34","first-page":"293","volume":"66","author":"G Speer","year":"2013","unstructured":"Speer, G. Impact of vitamin D in neurological diseases and neurorehabilitation: from dementia to multiple sclerosis. Part I: the role of vitamin D in the prevention and treatment of multiple sclerosis. Ideggyogy Sz. 66, 293\u2013303 (2013).","journal-title":"Ideggyogy Sz."},{"key":"74298_CR35","doi-asserted-by":"publisher","first-page":"101872","DOI":"10.1016\/j.msard.2019.101872","volume":"38","author":"A Sakoda","year":"2020","unstructured":"Sakoda, A. et al. Environmental risk factors for multiple sclerosis in Japanese people. Mult. Scler. Relat. Disord. 38, 101872 (2020).","journal-title":"Mult. Scler. Relat. Disord."},{"key":"74298_CR36","first-page":"1","volume":"19","author":"N Ghasemi","year":"2017","unstructured":"Ghasemi, N., Razavi, S. & Nikzad, E. Multiple sclerosis: pathogenesis, symptoms, diagnoses and cell-based therapy. Cell J. 19, 1 (2017).","journal-title":"Cell J."},{"key":"74298_CR37","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.jaad.2009.11.024","volume":"62","author":"JI Silverberg","year":"2010","unstructured":"Silverberg, J. I., Silverberg, A. I., Malka, E. & Silverberg, N. B. A pilot study assessing the role of 25 hydroxy vitamin D levels in patients with vitiligo vulgaris. J. Am. Acad. Dermatol. 62, 937\u2013941 (2010).","journal-title":"J. Am. Acad. Dermatol."},{"key":"74298_CR38","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.ajhg.2010.02.027","volume":"86","author":"Consortium, I. M. S. G","year":"2010","unstructured":"Consortium, I. M. S. G. Evidence for polygenic susceptibility to multiple sclerosis\u2014the shape of things to come. Am. J. Hum. Genet. 86, 621\u2013625 (2010).","journal-title":"Am. J. Hum. Genet."},{"key":"74298_CR39","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1093\/brain\/aws363","volume":"136","author":"P-A Gourraud","year":"2013","unstructured":"Gourraud, P.-A. et al. A genome-wide association study of brain lesion distribution in multiple sclerosis. Brain 136, 1012\u20131024 (2013).","journal-title":"Brain"},{"key":"74298_CR40","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1093\/aje\/kwk118","volume":"165","author":"H Schmidt","year":"2007","unstructured":"Schmidt, H., Williamson, D. & Ashley-Koch, A. HLA-DR15 haplotype and multiple sclerosis: a HuGE review. Am. J. Epidemiol. 165, 1097\u20131109 (2007).","journal-title":"Am. J. Epidemiol."},{"key":"74298_CR41","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1586\/14737175.2013.865867","volume":"13","author":"JR Oksenberg","year":"2013","unstructured":"Oksenberg, J. R. Decoding multiple sclerosis: an update on genomics and future directions. Expert Rev. Neurother. 13, 11\u201319 (2013).","journal-title":"Expert Rev. Neurother."},{"key":"74298_CR42","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fgene.2016.00003","volume":"7","author":"C Shen","year":"2016","unstructured":"Shen, C. et al. Genetic susceptibility to vitiligo: GWAS approaches for identifying vitiligo susceptibility genes and loci. Front. Genet. 7, 3 (2016).","journal-title":"Front. Genet."},{"key":"74298_CR43","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s10072-018-3617-6","volume":"40","author":"GM Hadjigeorgiou","year":"2019","unstructured":"Hadjigeorgiou, G. M. et al. Replication study of GWAS risk loci in Greek multiple sclerosis patients. Neurol. Sci. 40, 253\u2013260 (2019).","journal-title":"Neurol. Sci."},{"key":"74298_CR44","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.coi.2016.09.008","volume":"43","author":"JP Strassner","year":"2016","unstructured":"Strassner, J. P. & Harris, J. E. Understanding mechanisms of autoimmunity through translational research in vitiligo. Curr. Opin. Immunol. 43, 81\u201388 (2016).","journal-title":"Curr. Opin. Immunol."},{"key":"74298_CR45","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jaut.2015.06.010","volume":"64","author":"JA Hollenbach","year":"2015","unstructured":"Hollenbach, J. A. & Oksenberg, J. R. The immunogenetics of multiple sclerosis: a comprehensive review. J. Autoimmun. 64, 13\u201325 (2015).","journal-title":"J. Autoimmun."},{"key":"74298_CR46","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jns.2011.06.037","volume":"308","author":"I Kouri","year":"2011","unstructured":"Kouri, I. et al. HLA associations with multiple sclerosis in Greece. J. Neurol. Sci. 308, 28\u201331 (2011).","journal-title":"J. Neurol. Sci."},{"key":"74298_CR47","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41582-018-0082-z","volume":"15","author":"M Tintore","year":"2019","unstructured":"Tintore, M., Vidal-Jordana, A. & Sastre-Garriga, J. Treatment of multiple sclerosis\u2014success from bench to bedside. Nat. Rev. Neurol. 15, 53\u201358 (2019).","journal-title":"Nat. Rev. Neurol."},{"key":"74298_CR48","doi-asserted-by":"publisher","first-page":"e78","DOI":"10.1111\/j.1468-1331.2009.02563.x","volume":"16","author":"B Kocer","year":"2009","unstructured":"Kocer, B., Nazliel, B., Oztas, M. & Batur, H. Vitiligo and multiple sclerosis in a patient treated with interferon beta-1a: a case report. Eur. J. Neurol. 16, e78 (2009).","journal-title":"Eur. J. Neurol."},{"key":"74298_CR49","doi-asserted-by":"publisher","first-page":"e2233","DOI":"10.1212\/WNL.0000000000006648","volume":"91","author":"T Ruck","year":"2018","unstructured":"Ruck, T. et al. Vitiligo after alemtuzumab treatment: secondary autoimmunity is not all about B cells. Neurology 91, e2233\u2013e2237 (2018).","journal-title":"Neurology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-74298-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-74298-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-74298-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T21:46:48Z","timestamp":1670363208000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-74298-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,20]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["74298"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-74298-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,20]]},"assertion":[{"value":"28 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17792"}}